Showing 1,311 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

How HIV works

Scientists reveal HIV cell mystery

Editor's pick
The Age
21 September 2010
New & experimental HIV treatments

ICAAC: Novel HIV drug a 'trade-off'

Editor's pick
MedPage Today
17 September 2010
New & experimental HIV treatments

Poor adherence, high viral loads help explain rilpivirine treatment failures

Editor's pick
AIDSMeds.com
17 September 2010
Drug interactions & pharmacokinetics

Raltegravir Pharmacokinetics Disrupted by Antacids in Healthy Patients With HIV: Presented at ICAAC

Editor's pick
Doctor's Guide
16 September 2010
New & experimental HIV treatments

ICAAC: Study Closes Vicriviroc Story

Editor's pick
MedPage Today
16 September 2010
New & experimental HIV treatments

GSK new NNRTI selects no resistance mutations in 7 days of monotherapy

Editor's pick
NATAP
16 September 2010
New & experimental HIV treatments

K.U.Leuven enters license agreement with Pfizer to commercialize anti-HIV drugs

Editor's pick
News-Medical-Net
16 September 2010
New & experimental HIV treatments

New NRTI festinavir exhibits good anti-HIV activity and safety in phase 1b/2a study

Editor's pick
HIVandhepatitis.com
15 September 2010
New & experimental HIV treatments

Elvitegravir "Quad" single-tablet regimen shows continued HIV suppression at 48 weeks

Editor's pick
HIVandhepatitis.com
15 September 2010
New & experimental HIV treatments

Gilead Sciences submits European marketing application for once-daily single-tablet regimen of Truvada(R) and TMC278 for the treatment of HIV infection

Editor's pick
Market Watch
3 September 2010
New & experimental HIV treatments

AIDS cure quest to kill `sleeping' viruses enlists Merck cancer medicine

Editor's pick
Bloomberg
2 September 2010
New & experimental HIV treatments

Cocktails are next for cancer-drug makers

Editor's pick
Bloomberg Business Week
27 August 2010
New & experimental HIV treatments

Researchers Identify Two FDA Approved Drugs That May Fight HIV

Editor's pick
Science Daily
24 August 2010
New & experimental HIV treatments

Maraviroc potentially of benefit for many patients with late HIV diagnosis

News
16 August 2010
New & experimental HIV treatments

Chimerix's CMX157 Shows Potential to Treat Multi-Drug-Resistant HIV and Improve the Activity and Toxicity Profile of Tenofovir

Editor's pick
PR Newswire
28 July 2010
New & experimental HIV treatments

Therapeutic HIV vaccines show promise

Editor's pick
Scientific American
28 July 2010
New & experimental HIV treatments

Good results seen with NRTI-sparing regimens of atazanavir plus newer drug classes

News
26 July 2010
New & experimental HIV treatments

Once-daily extended-release nevirapine works as well as twice-daily formulation

News
23 July 2010
New & experimental HIV treatments

Experimental integrase inhibitor GSK-572 shows continued promise

News
23 July 2010
HIV treatment

Rilpivirine (TMC278) matches efavirenz in phase 3 studies, with fewer side-effects

News
22 July 2010
New & experimental HIV treatments

TBR-652 blocks both CCR5 and CCR2, inhibiting HIV replication and reducing inflammation

News
20 July 2010
New & experimental HIV treatments

Merck stops development of CCR5 inhibitor vicriviroc

News
15 July 2010
New & experimental HIV treatments

Avexa licenses integrase inhibitor to Chinese partner

Editor's pick
Avexa
14 July 2010
The search for a cure

HIV cure efforts severely underfunded, US activists report

News
13 July 2010